• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 RANK 基因座的 3D 染色体结构抑制骨髓瘤驱动的破骨细胞生成。

Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis.

机构信息

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

GLAZgo Discovery Centre, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

出版信息

Oncoimmunology. 2022 Aug 1;11(1):2104070. doi: 10.1080/2162402X.2022.2104070. eCollection 2022.

DOI:10.1080/2162402X.2022.2104070
PMID:35936985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9348127/
Abstract

Bone disease represents a major cause of morbidity and mortality in Multiple Myeloma (MM); primarily driven by osteoclasts whose differentiation is dependent on expression of RANKL by MM cells. Notably, costimulation by ITAM containing receptors (i.e., FcγR) can also play a crucial role in osteoclast differentiation. Modeling the pathology of the bone marrow microenvironment with an culture system of primary human multiple myeloma cells, we herein demonstrate that FcγR-mediated signaling, via staphylococcal protein A (SpA) IgG immune-complexes, can act as a critical negative regulator of MM-driven osteoclast differentiation. Interrogation of the mode-of-action revealed that FcγR-mediated signaling causes epigenetic modulation of chromosomal 3D architecture at the RANK promoter; with altered spatial orientation of a proximal super enhancer. Combined this leads to substantial down-regulation of RANK at a transcript, protein, and functional level. These observations shed light on a novel mechanism regulating RANK expression and provide a rationale for targeting FcγR-signaling for the amelioration of osteolytic bone pathology in disease.

摘要

骨骼疾病是多发性骨髓瘤(MM)患者发病率和死亡率的主要原因,主要由破骨细胞引起,其分化依赖于 MM 细胞表达的 RANKL。值得注意的是,含免疫球蛋白受体酪氨酸激活基序(ITAM)的受体(如 FcγR)的共刺激也可以在破骨细胞分化中发挥关键作用。通过原代人多发性骨髓瘤细胞的培养系统来模拟骨髓微环境的病理学,我们在此证明 FcγR 介导的信号通过葡萄球菌蛋白 A(SpA)IgG 免疫复合物,可以作为 MM 驱动的破骨细胞分化的关键负调节剂。作用机制的研究表明,FcγR 介导的信号导致 RANK 启动子处染色体 3D 结构的表观遗传修饰;近端超级增强子的空间取向发生改变。这导致 RANK 在转录本、蛋白质和功能水平上的大量下调。这些观察结果揭示了调节 RANK 表达的新机制,并为针对 FcγR 信号来改善疾病中的溶骨性骨病理提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/3ad3174266bf/KONI_A_2104070_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/1af52178055f/KONI_A_2104070_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/c726b8f9c8c1/KONI_A_2104070_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/fa1b545ae64a/KONI_A_2104070_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/3ad3174266bf/KONI_A_2104070_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/1af52178055f/KONI_A_2104070_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/c726b8f9c8c1/KONI_A_2104070_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/fa1b545ae64a/KONI_A_2104070_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf33/9348127/3ad3174266bf/KONI_A_2104070_F0004_OC.jpg

相似文献

1
Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis.靶向 RANK 基因座的 3D 染色体结构抑制骨髓瘤驱动的破骨细胞生成。
Oncoimmunology. 2022 Aug 1;11(1):2104070. doi: 10.1080/2162402X.2022.2104070. eCollection 2022.
2
expressing CD14CD16 monocytes expand in multiple myeloma patients leading to increased osteoclasts.表达CD14CD16的单核细胞在多发性骨髓瘤患者中增多,导致破骨细胞增加。
Haematologica. 2017 Apr;102(4):773-784. doi: 10.3324/haematol.2016.153841. Epub 2017 Jan 5.
3
Osteocyte CIITA aggravates osteolytic bone lesions in myeloma.破骨细胞 CIITA 加重骨髓瘤溶骨性骨病变。
Nat Commun. 2022 Jun 27;13(1):3684. doi: 10.1038/s41467-022-31356-7.
4
Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma.硒蛋白 W 参与多发性骨髓瘤中破骨细胞的过度激活分化。
Mol Biol Rep. 2024 Apr 29;51(1):587. doi: 10.1007/s11033-024-09517-2.
5
Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts.FcγR 和 IFNγR 途径的炎症激活共同影响破骨细胞的分化和活性。
Front Immunol. 2022 Sep 6;13:958974. doi: 10.3389/fimmu.2022.958974. eCollection 2022.
6
Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.免疫复合物诱导的破骨细胞生成抑制是通过激活骨髓前体细胞上的而不是抑制性 Fcγ 受体来介导的。
Ann Rheum Dis. 2013 Feb;72(2):278-85. doi: 10.1136/annrheumdis-2012-201568. Epub 2012 Aug 23.
7
[The role of RANK/RANKL and OPG in multiple myeloma].RANK/RANKL和骨保护素在多发性骨髓瘤中的作用
Postepy Hig Med Dosw (Online). 2006;60:471-82.
8
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.RANK/RANK配体系统参与人骨髓瘤细胞在骨髓微环境中对白细胞介素-6和白细胞介素-11的上调作用。
Haematologica. 2004 Sep;89(9):1118-23.
9
DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.DOK3 通过负向调节破骨细胞生成和正向调节成骨细胞生成来调节骨重塑。
J Bone Miner Res. 2017 Nov;32(11):2207-2218. doi: 10.1002/jbmr.3205. Epub 2017 Aug 2.
10
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro.多发性骨髓瘤患者的未成熟树突状细胞易于体外破骨细胞分化。
Exp Hematol. 2011 Jul;39(7):773-83.e1. doi: 10.1016/j.exphem.2011.04.006. Epub 2011 Apr 25.

本文引用的文献

1
Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scripts.Searchlight:使用动态生成的 R 脚本进行自动化批量 RNA-seq 探索和可视化。
BMC Bioinformatics. 2021 Aug 19;22(1):411. doi: 10.1186/s12859-021-04321-2.
2
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.染色质构象特征可作为预测早期类风湿关节炎患者对甲氨蝶呤治疗反应不足的标志物。
J Transl Med. 2018 Jan 29;16(1):18. doi: 10.1186/s12967-018-1387-9.
3
Characteristics of functional enrichment and gene expression level of human putative transcriptional target genes.
人类推测转录靶基因的功能富集特征和基因表达水平。
BMC Genomics. 2018 Jan 19;19(Suppl 1):957. doi: 10.1186/s12864-017-4339-5.
4
Uncovering direct and indirect molecular determinants of chromatin loops using a computational integrative approach.使用计算整合方法揭示染色质环的直接和间接分子决定因素。
PLoS Comput Biol. 2017 May 23;13(5):e1005538. doi: 10.1371/journal.pcbi.1005538. eCollection 2017 May.
5
Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.小鼠抑瘤素M通过白血病抑制因子受体作用使信号转导和转录激活因子3(STAT3)磷酸化,但不使STAT1磷酸化,该效应可保护骨量。
J Biol Chem. 2016 Oct 7;291(41):21703-21716. doi: 10.1074/jbc.M116.748483. Epub 2016 Aug 18.
6
Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.静脉注射免疫球蛋白(IVIG)可减轻肿瘤坏死因子(TNF)诱导的病理性骨吸收,并通过诱导A20表达抑制破骨细胞生成。
J Cell Physiol. 2016 Feb;231(2):449-458. doi: 10.1002/jcp.25091.
7
Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss.免疫球蛋白G的糖基化决定破骨细胞分化和骨质流失。
Nat Commun. 2015 Mar 31;6:6651. doi: 10.1038/ncomms7651.
8
Immune complexes regulate bone metabolism through FcRγ signalling.免疫复合物通过 FcRγ 信号调节骨代谢。
Nat Commun. 2015 Mar 31;6:6637. doi: 10.1038/ncomms7637.
9
Super-enhancers delineate disease-associated regulatory nodes in T cells.超级增强子描绘了T细胞中与疾病相关的调控节点。
Nature. 2015 Apr 23;520(7548):558-62. doi: 10.1038/nature14154. Epub 2015 Feb 16.
10
Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease.骨免疫学:抑瘤素M作为健康与疾病中骨形成和骨吸收的多效性调节因子
Bonekey Rep. 2014 May 14;3:527. doi: 10.1038/bonekey.2014.22. eCollection 2014.